Biomarkers to predict FDG PET/CT activity after the standard duration of treatment for spinal tuberculosis: An exploratory study

Towards more accurate 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) imaging in Active and Latent Tuberculosis

(2020) Dimitris Priftakis et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Sequential 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) scan findings in patients with extrapulmonary tuberculosis during the course of treatment—a prospective observational study

(2020) Jamshed Bomanji et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Prospective evaluation of host biomarkers other than interferon gamma in QuantiFERON Plus supernatants as candidates for the diagnosis of tuberculosis in symptomatic individuals

(2019) Portia M. Manngo et al.   JOURNAL OF INFECTION

FDG-PET/CT AS A NON-INVASIVE BIOMARKER FOR ASSESSING ADEQUACY OF TREATMENT AND PREDICTING RELAPSE IN PATIENTS TREATED FOR PULMONARY TUBERCULOSIS

(2019) Ismaheel Lawal et al.   JOURNAL OF NUCLEAR MEDICINE

Distinct serum biosignatures are associated with different tuberculosis treatment outcomes

(2019) Katharina Ronacher et al.   TUBERCULOSIS

Accumulate evidence for IP-10 in diagnosing pulmonary tuberculosis

(2019) Xia Qiu et al.   BMC INFECTIOUS DISEASES

Spinal tuberculosis

(2018) R. N. Dunn et al.   Bone & Joint Journal

Child and adult spinal tuberculosis at tertiary hospitals in the Western Cape, South Africa: 4-year burden and trend

(2018) T. N. Mann et al.   EPIDEMIOLOGY AND INFECTION

The changing epidemiology of spinal tuberculosis: the influence of international immigration in Catalonia, 1993–2014

(2017) M. PEGHIN et al.   EPIDEMIOLOGY AND INFECTION

The epidemiology of spinal tuberculosis in the United States: an analysis of 2002–2011 data

(2017) Rafael De la Garza Ramos et al.   JOURNAL OF NEUROSURGERY-SPINE

Host blood RNA signatures predict the outcome of tuberculosis treatment

(2017) Ethan G. Thompson et al.   TUBERCULOSIS

Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial

(2017) G.B. Sigal et al.   EBioMedicine

Tuberculosis of spine: Research evidence to treatment guidelines

(2016) AnilK Jain   Indian Journal of Orthopaedics

Serum inflammatory profiles in pulmonary tuberculosis and their association with treatment response

(2016) Rihwa Choi et al.   Journal of Proteomics

Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure

(2016) Stephanus T Malherbe et al.   NATURE MEDICINE

Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB

(2016) Novel N Chegou et al.   THORAX

Identification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response

(2016) Ruschca Jacobs et al.   Oncotarget

Tomografia por emissão de pósitrons com 18F‐fluordesoxiglicose e citocinas séricas e metaloproteinases da matriz na avaliação da atividade da doença na arterite de Takayasu

(2016) Anne E.D. Arraes et al.   Revista Brasileira De Reumatologia

Characteristics and Clinical Outcome of Bone and Joint Tuberculosis From 1994 to 2011: A Retrospective Register-based Study in Denmark

(2015) Isik S. Johansen et al.   CLINICAL INFECTIOUS DISEASES

IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy

(2015) I. Wergeland et al.   JOURNAL OF INFECTION

Cytokines for monitoring anti-tuberculous therapy: A systematic review

(2015) Vanessa Clifford et al.   TUBERCULOSIS

Cytokine Kinetics in the First Week of Tuberculosis Therapy as a Tool to Confirm a Clinical Diagnosis and Guide Therapy

(2015) Alice L. den Hertog et al.   PLoS One

Potential role of F18 FDG PET-CT as an imaging biomarker for the noninvasive evaluation in uncomplicated skeletal tuberculosis: a prospective clinical observational study

(2014) Sugandha Dureja et al.   EUROPEAN SPINE JOURNAL

Mycobacterium tuberculosis 10-kDa co-chaperonin regulates the expression levels of receptor activator of nuclear factor-κB ligand and osteoprotegerin in human osteoblasts

(2014) YUANYU ZHANG et al.   Experimental and Therapeutic Medicine

World Medical Association Declaration of Helsinki

(2013)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

FDG-PET Imaging in HIV Infection and Tuberculosis

(2013) Mike Sathekge et al.   SEMINARS IN NUCLEAR MEDICINE

Infection Dynamics and Response to Chemotherapy in a Rabbit Model of Tuberculosis using [18F]2-Fluoro-Deoxy-d-Glucose Positron Emission Tomography and Computed Tomography

(2012) Laura E. Via et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Drug therapy in spinal tuberculosis

(2012) S. Rajasekaran et al.   EUROPEAN SPINE JOURNAL

Efficacy of extended DOTS category I chemotherapy in spinal tuberculosis based on MRI-based healed status

(2012) AnilK Jain et al.   Indian Journal of Orthopaedics

Plasma cytokines and chemokines differentiate between active disease and non-active tuberculosis infection

(2012) Adane Mihret et al.   JOURNAL OF INFECTION

The chemotherapy of osteo-articular tuberculosis with recommendations for treatment of children

(2011) P.R. Donald   JOURNAL OF INFECTION

PET/CT scanning with a high HIV/AIDS prevalence

(2011) J.M. Warwick et al.   TRANSFUSION AND APHERESIS SCIENCE

Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis

(2009) J. F. Djoba Siawaya et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging in Pyogenic and Tuberculous Spondylitis

(2009) In Sook Lee et al.   JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY